Centre Number
Candidate Number
Write your name here
Surname
Other names
Total Marks
Paper Reference
Turn over    
P45032A
©2015 Pearson Education Ltd.
1/1/1/1/1/1/
*P45032A0128*
Biology
Advanced
Unit 5:  Energy, Exercise and Coordination
Thursday 15 January 2015 – Morning
Time: 1 hour 45 minutes
WBI05/01
You must have:
A copy of the scientific article (enclosed), calculator
Instructions
•	Use black ink or ball-point pen.
•	Fill in the boxes at the top of this page with your name,  
	
centre number and candidate number.
•	Answer all questions.
•	Answer the questions in the spaces provided  
	
– there may be more space than you need.
Information
•	 The total mark for this paper is 90. 
•	 The marks for each question are shown in brackets
	
– use this as a guide as to how much time to spend on each question.
•	 Questions labelled with an asterisk (*) are ones where the quality of your  
	
written communication will be assessed
	
– you should take particular care with your spelling, punctuation and grammar, as 
well as the clarity of expression, on these questions.
•	 Candidates may use a calculator.
Advice
•	 Read each question carefully before you start to answer it.
•	 Keep an eye on the time.
•	 Try to answer every question.
•	 Check your answers if you have time at the end.
Pearson Edexcel 
International
Advanced Level
PMT


--- Page Break ---

2
*P45032A0228*
Answer ALL questions.
Some questions must be answered with a cross in a box .  If you change your mind about an 
answer, put a line through the box 
 and then mark your new answer with a cross .
1	 Organisms need to coordinate responses to changes in their environment.  
The mechanism of coordination in animals can be nervous or hormonal.
	
(a)	 Place a cross  in the box next to the answer that correctly compares nervous 
coordination with hormonal coordination. 
(1)
	
	
	
A	 nervous coordination is faster and lasts for a longer time
	
	
	
B	 nervous coordination is faster and lasts for a shorter time
	
	
	
C	 nervous coordination is slower and lasts for a longer time
	
	
	
D	 nervous coordination is slower and lasts for a shorter time
	
(b)	 The response to light in humans involves rod cells as receptors. 
	
	
(i)	 Place a cross  in the box below the diagram that shows the direction light 
takes when it stimulates a rod cell.
(1)
	
A	
B	
C	
D
Light
Light
Light
Light
PMT


--- Page Break ---

3
*P45032A0328*
Turn over    
	
	
(ii)	 Place a cross  in the box next to the part of the rod cell that contains 
rhodopsin.
(1)
	
	
(iii)	Place a cross  in the box next to the description of what happens when a 
molecule of rhodopsin is bleached by light.
(1)
	
	
	
A	 opsin changes to retinal
	
	
	
B	 retinal changes to opsin
	
	
	
C	 trans-retinal changes to cis-retinal
	
	
	
D	 cis-retinal changes to trans-retinal
	
	
(iv)	Bleaching of rhodopsin leads to hyperpolarisation of the rod cell membrane. 
Place a cross  in the box next to the description of what happens during 
hyperpolarisation.
(1)
	
	
	
A	 sodium ion channels close while the sodium ion pump stops working
	
	
	
B	 sodium ion channels close while the sodium ion pump continues to work 
	
	
	
C	 sodium ion channels open while the sodium ion pump continues to work
	
	
	
D	 sodium ion channels open while the sodium ion pump stops working
A
B
C
D
PMT


--- Page Break ---

4
*P45032A0428*
	
(c)	 Coordination in plants involves IAA (auxin).
	
	
In an experiment, 25 mm lengths of stem were cut and placed in five dishes. 
A different concentration of IAA was added to each dish.  The dishes were left for 
24 hours and the mean increase in stem length was recorded. 
	
	
The results are shown in the table below.
Dish
IAA concentration
/ mg dm−3
Mean increase in 
stem length / mm
1
0.00
2.5 ± 1.0
2
0.01
2.1 ± 1.5
3
0.10
5.0 ± 1.1
4
1.00
6.8 ± 4.0
5
10.00
7.8 ± 3.2
	
	
(i)	 Use the information in the table to describe the effect of IAA concentration on 
the mean increase in stem length.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(ii) 	Suggest one other variable that needs to be controlled in this experiment.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

5
*P45032A0528*
Turn over    
	
	
(iii)	It is important that the calculated means are reliable. 
	
	
	
Using the information in the table, state the mean result that is the least 
reliable.  Give a reason for your answer. 
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 1 = 9 marks)
PMT


--- Page Break ---

6
*P45032A0628*
2	 The diagram below shows a spirometer that can be used to measure lung volumes. 
A spirometer can also be used to measure the volume of oxygen a person uses.
	
(a)	 A student used a spirometer to measure the volume of oxygen he used at rest 
and during exercise.
	
	
The spirometer trace below shows the results he obtained during exercise. 
Spirometer trace
Pen
Movable lid
Counterbalance
Mouthpiece
Oxygen inlet
Container for 
carbon dioxide 
absorber
0
1
2
3
4
5
0
20
40
20
40
60
80
100
120
140
Time / s
P
Q
Volume of oxygen / dm3
PMT


--- Page Break ---

7
*P45032A0728*
Turn over    
	
	
(i)	 The line P to Q slopes downwards because oxygen is being used.
	
	
	
Use the line, labelled P to Q on the trace, to calculate the volume of oxygen 
used during one minute of exercise.
(1)
Volume of oxygen used = ..............................................................
	
	
(ii)	 The student had a body mass of 70 kg. 
	
	
	
Calculate the rate of oxygen used by this student in dm3 kg−1 h−1. 
	
	
	
Show your working.
(2)
Rate of oxygen used = .............................................................. dm3 kg−1 h−1
	
	
(iii)	Suggest two differences between this spirometer trace and the one the 
student obtained at rest.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(b)	 (i)	 The air the student exhaled passed through the carbon dioxide absorber in 
the spirometer.
	
	
	
Name a carbon dioxide absorber.
(1)
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

8
*P45032A0828*
	
	
(ii)	 Explain why the spirometer trace would be different if the carbon dioxide had 
not been absorbed. 
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(c) 	Explain how carbon dioxide is involved in the control of breathing rate during 
exercise.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
......................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 2 = 12 marks)
PMT


--- Page Break ---

9
*P45032A0928*
Turn over    
3	 Nerve impulses are transmitted along the axon of a neurone.
	
(a)	 The diagram below shows the structure of a motor neurone.
	
	
(i)	 Place a cross  in the box next to the part of the neurone labelled T.
(1)
	
	
	
A	 dendrite
	
	
	
B	 node of Ranvier
	
	
	
C	 Schwann cell
	
	
	
D	 synapse
T
PMT


--- Page Break ---

10
*P45032A01028*
	
	
(ii)	 The graph below shows changes in the membrane potential during the 
transmission of an impulse along the axon of a motor neurone.
	
	
	
Place a cross  in the box next to the description of the membrane potential 
at 0.75 ms on the graph. 
(1)
	
	
	
A	 depolarised
	
	
	
B	 hyperpolarised
	
	
	
C	 polarised
	
	
	
D	 repolarised
	
	
(iii)	Explain how the structure of this motor neurone affects the speed of the 
impulse along the axon.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
−90
−70
−50
−30
−10
+10
+30
+50
0.5
1.0
1.5
2.0
2.5
Time / ms
Transmembrane potential / mV
PMT


--- Page Break ---

11
*P45032A01128*
Turn over    
	
(b)	 The photograph shows a golden poison frog (Phyllobates terribilis).
Magnification ×1
	
	
The skin of this frog produces a poison that affects sodium ion channels in the 
axon membrane of a neurone.  The poison causes these channels to stay open.
	
	
(i)	 Explain the effect the poison has on the ability of a neurone to transmit impulses.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
......................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

12
*P45032A01228*
	
	
(ii)	 Suggest why the neurones of the golden poison frog are not affected if they 
come into contact with the poison. 
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 3 = 10 marks)
PMT


--- Page Break ---

13
*P45032A01328*
Turn over    
blank page
PMT


--- Page Break ---

14
*P45032A01428*
4	 Exercise is important for human health.
	
The graph below shows how level of exercise changes the risk of death in young and 
old people.
	
(a)	 Use the information in the graph to describe the effect of level of exercise on the 
percentage risk of death. 
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
0
10
20
30
40
50
60
70
80
20
40
60
80
30
50
70
Percentage risk of death (%)
Level of exercise / arbitrary units
Old
Young
PMT


--- Page Break ---

15
*P45032A01528*
Turn over    
	
(b)	 State the effect of exercise on each of the following.
	
	
(i)	 The risk of having diabetes and being obese.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(ii)	 The immune system.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(c)	 Exercise has an effect on the risk of having coronary heart disease (CHD). 
In people with CHD the heart muscle cells receive less oxygen.
	
	
*(i)	 Describe how heart muscle cells make ATP when less oxygen is available. 
(6)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

16
*P45032A01628*
	
	
(ii)	 A person will suffer a pain called angina if heart muscle cells receive less oxygen.
	
	
	
Suggest how lack of oxygen in heart muscle cells can cause angina.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 4 = 13 marks)
PMT


--- Page Break ---

17
*P45032A01728*
Turn over    
5	 Some animals, such as spiders, bite and inject venom into their prey.  The venom 
affects the transmission of nerve impulses and paralyses the prey. 
	
In an investigation, scientists estimated the toxicity of the venom by measuring the 
dose that can kill 50% of prey after injection.  This dose is called the LD50.
	
The graph below shows the relationship between the percentage of prey killed and 
the dose of venom A and venom B.
	
(a)	 (i)	 Use the information in the graph to compare the toxicity of venom A and 
venom B.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
0
50
100
0
5
10
15
A
B
Percentage of 
prey killed (%)
Dose of venom / mg kg−1
PMT


--- Page Break ---

18
*P45032A01828*
	
	
(ii)	 Place a cross  in the box next to the independent variable in this investigation.
	
	
	
A	 dose of venom
	
	
	
B	 mass of the prey
	
	
	
C	 percentage of prey killed
	
	
	
D	 toxicity of the venom
(1)
	
(b)	 Two scientists, P and Q, investigated the LD50 values for the venom produced by four 
species of spider.  Their results are shown in the table below.
Scientist
Species of spider 
LD50
P
L. mactans
0.002  mg kg−1
H. huwenum
0.700  mg kg−1
Q
P. bahiensis
0.610  µg kg−1
A. robustus
160.0  µg kg−1
	
	
Scientist P measured the toxicity in mg kg −1 and scientist Q measured the  
toxicity in µg kg−1.  One µg is equal to 0.001mg.
	
	
Name the species with the most toxic venom.
(1)
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

19
*P45032A01928*
Turn over    
	
(c)	 The venom from L. mactans (black widow spider) causes constant impulses to be 
sent along motor neurones.  This results in cramps (constant muscle contractions), 
a symptom of a black widow spider bite.
	
	
Suggest how constant impulses along motor neurones cause cramps.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 5 = 8 marks)
PMT


--- Page Break ---

20
*P45032A02028*
6	 The electron transport chain is involved in the synthesis of ATP. 
	
(a)	 The diagram below shows part of the electron transport chain.
	
	
(i)	 Name the molecules P, Q and R.
(3)
	
P ......................................................................................................................................
	
Q ......................................................................................................................................
	
R ......................................................................................................................................
	
	
(ii)	 Place a cross  in the box next to the description of where the electron 
transport chain occurs.
(1)
	
	
	
A	 cytoplasm surrounding mitochondria
	
	
	
B	 inner mitochondrial membrane
	
	
	
C	 mitochondrial matrix
	
	
	
D	 outer mitochondrial membrane
reduced NAD
P
R
Q
ATP
ATP
ATP
carrier
(oxidised)
carrier
(reduced)
carrier
(oxidised)
carrier
(reduced)
carrier
(oxidised)
carrier
(reduced)
PMT


--- Page Break ---

21
*P45032A02128*
Turn over    
	
(b)	 In 2013, poachers killed over 80 elephants in Zimbabwe by poisoning their 
drinking water with cyanide.  Cyanide inhibits cytochrome oxidase, the last carrier 
in the electron transport chain.
	
	
Suggest how inhibiting cytochrome oxidase would kill an elephant.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 6 = 8 marks)
PMT


--- Page Break ---

22
*P45032A02228*
7	 The scientific article you have studied has been adapted from a Royal Society publication.  
Use the information in the article and your own knowledge to answer the following 
questions.
	
(a)	 Scientists are encouraged to use non-animal alternatives in their research 
(paragraphs 3 and 5). 
	
	
Name one non-animal alternative that can be used in research and give an 
advantage of this alternative method.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(b)	 Explain why new medicines are tested on animals before they are tested on 
humans (paragraph 7).
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

23
*P45032A02328*
Turn over    
	
(c)	 The article states that “Molecular mechanisms and those involved in cell 
differentiation and propagation are frequently identical across a wide range of 
species” (paragraph 11).
	
	
Discuss this statement by making reference to the molecular mechanisms 
involved in switching genes on and off.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(d)	 Suggest the advantages of using mice as a “knock out” model in research 
compared with the use of humans (paragraph 12).
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

24
*P45032A02428*
	
(e)	 Suggest how the experimental design for the testing of thalidomide could have 
been improved (paragraph 13).
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(f)	 State what is meant by the term mouse genome (paragraph 15).
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(g)	 Explain why animals had to be used to test the polio vaccine (paragraphs 17 and 18).
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

25
*P45032A02528*
	
(h)	 The article states that drug-resistant infections “are a major problem in both 
developed and developing countries” (paragraph 22).
	
	
Explain how drug-resistance evolves in organisms that cause infection. 
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(i)	 The article discusses absolutism as an ethical position with regard to animal 
testing (paragraphs 28 and 29).
	
	
Suggest what is meant by the term absolutism. 
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
Turn over    
PMT


--- Page Break ---

26
*P45032A02628*
	
(j)	 The article states that there is an “alternative to such absolutism” (paragraph 29). 
People who believe in this alternative ethical position are called relativists.
	
	
Suggest the opinion a relativist would have with regard to using animals in research. 
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
......................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(k)	 The article states that scientists who use animals for testing are expected “to 
reduce the number of animals used in research to the minimum required for 
meaningful results” (paragraph 37).
	
	
Explain why reducing numbers below the minimum required could produce 
results that are not meaningful.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

27
*P45032A02728*
	
(l)	 Suggest how gene therapy for “motor neuron degeneration diseases” such as ALS 
might be carried out (paragraph 42).
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
Turn over    
PMT


--- Page Break ---

28
*P45032A02828*
	
*(m)	An investigation that used animals was carried out by Hubel and Weisel.  These 
scientists used kittens to investigate brain development. 
	
	
Explain how this work helped to develop explanations of human brain development.
(5)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 7 = 30 marks)
TOTAL FOR PAPER = 90 MARKS
PMT


--- Page Break ---

Paper Reference
Turn over    
Biology
Advanced
Unit 5: Energy, Exercise and Coordination
January 2015
Scientific Article for use with Question 7
WBI05/01
Do not return the Insert with the question paper.
P45032A
©2015 Pearson Education Ltd.
1/1/1/1/1/1/
*P45032A*
Pearson Edexcel International Advanced Level
PMT


--- Page Break ---

2
P45032A
Scientific article for use with Question 7
Animal Testing
1.	 Humans have benefited immensely from scientific research involving animals, with virtually every 
medical achievement in the past century reliant on the use of animals in some way.  Developments 
in the treatment of diabetes, leukaemia and heart surgery transplants, amongst others, have been 
made possible through the use of animals in scientific research.  The majority of the scientific 
community consider that the benefits that have been provided by the use of animals in research 
justify this use. The public also increasingly accepts the use of animals in research.  Polls have shown 
that 90% of the public accepted the need for the use of animals, providing that certain research 
conditions were met, which are: there is no unnecessary suffering; the research is for serious 
medical or life-saving purposes; and there is no reliable and informative alternative to their use. 
2. 	 It is important to recognise that although a significant proportion of work using animals is basic 
research whose benefits to health are not immediately evident, this work is highly valuable as it 
provides the groundwork for future medical advances. The appropriate moral stance for all use 
of animals in research is to minimise animal suffering and maximise the benefits to medicine and 
health, agriculture and fundamental understanding. 
3.	 Animal research only takes place after careful evaluation and within a framework of robust controls. 
UK legislation requires that researchers refine their procedures to keep suffering to the minimum, 
ensure the number of animals is reduced to the minimum required for meaningful results, and seek 
to replace the use of animals with non-animal alternatives where appropriate.  However, the use of 
non-animal alternatives may not be appropriate for some types of research, and these experiments 
may be permitted provided they are designed to keep pain and suffering to a minimum.
4.	 The majority of research using animals (84%) involves the use of rodents as experimental subjects, 
with the use of non-human primates for research purposes, which are subject to particularly rigorous 
control due to the special protection granted to them under the 1986 Act, accounting for less than 
one percent of total animal experiments.  Basic research and drug development accounted for 82% 
of all procedures, with safety testing accounting for the remaining 18%.
5.	 Opponents of the use of animals in research frequently use the availability of alternative, non-
animal, research methods as evidence that research using animals is unnecessary.  It is true that 
non-animal methods, such as tissue culture, computer modelling, research using human test 
subjects and population studies, are frequently used and have utility for scientific and medical 
research.  However, these methods are generally used in addition to animal studies, and do not 
replace them.
6.	 It is rarely possible to replace animals with a non-animal alternative.  This is because a research 
study often requires more than knowing how individual molecules, cells or tissues behave.  Instead, 
scientific research, and medical research in particular, often depends on understanding not only the 
processes of the living body but how they interact.
7.	 It is unethical and illegal to expose human patients to new medicines without being confident 
that they are likely to benefit and not be seriously harmed, so the only alternative is to use the 
most suitable animal to study a particular disease or biological function.  Additionally, in drug 
development, animal tests are used to establish both the benefits and the potential toxicity 
of substances and ensure that human volunteer studies are carried out with a full scientific 
understanding of the substance involved, to maximise the benefits and avoid possible serious side 
effects.
PMT


--- Page Break ---

3
P45032A
Turn over    
8.	 Within this article, the following issues are considered: examples of medical advances that have 
been achieved through the use of animals; the theoretical framework behind the use of animals; 
the legislation that regulates the use of animals; and discussion of philosophies that underpin the 
debate about the use of animals in research.  This article is not intended to be a manual of how to 
conduct research.  Nor is it a substitute for good advice on experimental design, statistical analysis 
or any of the other aspects of conducting a successful research project.
9.	 The understanding of the human body has come from more than 200 years of research on the 
function of normal cells, tissues and organs, and on disease processes.  Much of this understanding 
has been facilitated by research that was performed on animals.  This fundamental knowledge 
underpins the teaching of medicine and veterinary medicine and has been instrumental in the 
development of medical advances for both people and animals.
10.	It is no exaggeration to say that almost every form of conventional medical treatment, such as drugs, 
vaccines, radiation or surgery, rests in part on the study of animals.  However, this fundamental link 
is frequently not appreciated and the following examples illustrate some of the important medical 
advances that have resulted directly from animal experiments.
11.	Model species are used to test possibilities that would be difficult or impossible to test using the 
target species.  In general, one species may be used as a model for another when, despite other 
differences between them, the two species strongly resemble each other in particular ways. 
Molecular mechanisms and those involved in cell differentiation and propagation are frequently 
identical across a wide range of species.  Therefore, for some of the most fundamental principles of 
biology, using animals as models can provide valuable insight into human cell processes. 
12.	Animal models also enable a much greater control of experimental conditions than could reasonably 
be achieved in humans.  Human patients can be highly heterogenous in disease symptoms and 
their behavioural variability, such as differences in patients’ compliance with instructions, is far more 
significant in human trials.  In certain uses of animals as models, such as mouse ‘knock-out’ models, 
in which individual genes are switched off to study the effect, researchers can even control the 
genetic make-up of the experimental subjects to ensure homogeneity.
13.	Opponents to the use of animals in research claim that using animals as models for humans is 
invalidated by the differences between humans and animals.  Evidence presented to support 
this argument includes the case of the unpredicted limb defects that occurred in the children of 
women who took the drug thalidomide during pregnancy.  It is true that the damaging effects of 
thalidomide on developing embryos were not predicted in the initial animal experiments but this 
is because the effects of thalidomide during pregnancy were not looked for.  Had the researchers 
at the time attempted to anticipate these effects, then research conducted using pregnant animal 
research subjects would have been able to detect these effects, as seen in later studies conducted 
after the effects of thalidomide in humans were discovered and the drug was withdrawn.
14.	It is important to emphasise that animals are normally highly accurate models for humans, and in 
this instance it was experimental design that failed to look for the teratogenic effects, not that the 
experiments failed to detect the effects.  The similarity between some animals and humans is best 
demonstrated by the fact that many drugs can be used to treat both human and animal patients, 
such as antibiotics and tranquillisers.
PMT


--- Page Break ---

4
P45032A
15.	The last two decades have witnessed a revolution in biology with the sequencing of the human, 
mouse and fly genomes.  A wealth of information has been produced about the role of genes 
and gene products in some diseases, as well as providing insight on why some people respond 
to some medicines better than others.  The knowledge now available from the sequencing of the 
human, mouse and fly genomes has enabled genetic modification of animals to produce highly 
specific models of diseases, helping to identify disease pathways and aid the development of new 
therapies. 
16.	Following are three case studies that provide examples of medical advances that have been 
developed through the use of animals in research.
Case study on polio vaccine
17.	An example of the use of animals as models of human cell processes is the development of polio 
vaccine.  Polio is an infectious disease that can strike at any age but mainly affects children under 
three years old, and is prevalent in developing countries.  The polio virus enters through the mouth 
and once it enters the blood stream can invade the central nervous system, destroying nerve cells 
in the limbs, trunk and the brainstem, resulting in paralysis and sometimes death.  Soon after 
the introduction of effective vaccines in the late 1950s and early 1960s, polio was brought under 
control, and practically eliminated as a public health problem in industrialized countries.  Research 
into polio vaccine requires the use of living nerve tissue to ensure that the virus used for vaccine 
production causes the paralysis typical of polio, and no human or tissue culture alternative is 
available.
18.	Additionally the polio vaccine uses a live attenuated virus, which is notorious for sometimes 
reverting to virulence, so animals are still the only practical way of predicting the potential virulence 
of each batch of polio vaccine.  As a result of this potential risk to humans, each batch of vaccine is 
tested in animals.  This previously involved an intra-cerebral injection of the vaccine into monkeys, 
which is highly predictive of virulence.
19.	More recently mice have been genetically engineered to have the receptors for the virus, providing 
animal models of the disease.  Despite the many differences between mice and humans, the use 
of genetically modified (GM) mice to establish the virulence of the vaccine provides an accurate 
model of humans in this respect.  This is a good illustration of how mice, and in particular GM mice, 
can be used as models for human pathogens.  Besides being genetically similar to humans, mice 
are small and inexpensive to maintain.  Their short life span and rapid reproductive rate make it 
possible to study disease processes in many individuals, thus gaining a greater understanding of 
the progression of the disease within a short space of time.
Drugs for the future
20.	A great number of diseases remain for which drug therapies are far from optimal or even nonexistent. 
Many drug targets are proteins and the completion of the human genome project, the blueprint 
for around 30 000 human genes and 250 000 proteins, has enabled the genes encoding for these 
proteins to become known and provides potential for a greater understanding of disease at the 
molecular level than at any other point in history.
PMT


--- Page Break ---

5
P45032A
Turn over    
21.	Techniques such as genomics and proteomics can help provide a wealth of information about these 
proteins such as their functional role, and can help refine experimental procedures, but they cannot 
substitute for the complexity provided by whole subject studies for increasing understanding 
and developing treatments of disease.  The long and complex route from discovery to drug will 
inevitably require the use of animals at some stage of the scientific investigation and it is important 
to realise the limitations of non-animal techniques.
22.	Many challenges to the healthcare systems of both developed and developing countries exist that 
would benefit from the use of animals in research.  Examples include: drug-resistant infections, 
which are a major problem in both developed and developing countries, frequently involve 
examination of disease progression and research could benefit from the use of animal models such 
as genetically modified mice; mental illnesses, especially depression, schizophrenia and anxiety, 
which require a holistic approach, involving molecular, cellular and whole animal studies; better 
treatments for diseases of bone, joints and the immune system, all of which involve complex 
interactions throughout the body; treatment of diseases of genetic origin, such as Duchenne 
muscular dystrophy, which could utilise genetically modified animals to mimic human patients; 
blindness and deafness, which involve analysis of these functions in living research subjects; 
HIV infection and AIDS, with animal models of the disease required to develop and test possible 
vaccines or antiviral agents before trials can be safely conducted in humans; senile dementia and 
other complications of old age, where the cause and progression of these conditions is poorly 
understood at present, and require detailed examination of the brain and nervous system in animal 
models.
Case study on cystic fibrosis
23.	Cystic fibrosis is an example of a disease where future therapies are being developed through the 
use of genomics.  Much research is focused on correcting the genetic deficiencies that lead to the 
disease either by gene therapy, which would turn the faulty protein into a functional protein, or 
by finding alternate pathways to bypass the need for the protein.  The cystic fibrosis gene, cystic 
fibrosis transmembrane-conductance regulator or CFTR, codes for a large protein, CFTR protein, 
that functions as an epithelial chloride channel and has a regulatory influence on many other 
cellular proteins.  Without a functional form of this protein a person suffers from a lethal genetic 
disease, cystic fibrosis.
24.	In other conditions, such as the secretory diarrhoeas associated with cholera, CFTR is a key player 
in the devastating loss of bodily fluid.  The need to discover high affinity ligands that interact with 
both CFTR protein and some of the common faulty forms of this protein is key to the development 
of cystic fibrosis therapies.  A recent search for CFTR ligands was carried out using cells in culture 
expressing CFTR protein and a halide indicator, as normal CFTR functions as a chloride channel. 
In a recent search for agents that activated or inhibited the channel, CFTR protein was expressed 
in cultured cells that also contained a reporter molecule that altered its fluorescence when either 
chloride (or other halide) entered or left the cells.
25.	By screening 50,000 diverse compounds, six compounds were discovered that blocked the activity 
of CFTR protein and further chemical modification led to several channel blockers with sub-
micromolar activity.  Having identified these six lead compounds using non-animal methods, 
further research was then carried out by testing in mice to establish the most active compound. 
What this example shows is the multiple methodologies involved in testing a potential therapy, 
and that the use of animals remains a key stage.  The search for CFTR activators continues, which 
may prove useful for future therapies for cystic fibrosis, and further investigations will undoubtedly 
require the use of transgenic animals bearing common mutations of the CFTR gene.
PMT


--- Page Break ---

6
P45032A
Ethical approaches to the use of animals
26.	All those involved in the debate about the use of animals in research lay claim to one or other moral 
principle.  In human and veterinary medicine, causing pain or suffering in a patient is considered 
unethical unless it is for the direct benefit of that patient. Those who favour work on animals may 
do so to alleviate the suffering of humans or other animals.  Scientists in favour of this principle use 
their research to understand fundamental aspects of biology that in turn facilitate the development 
of therapeutic measures for both animals and humans.  Those who oppose the use of animals in 
research may object to the means by which scientists attempt to achieve their goals. 
27.	One view is that each animal has the right to life and humans should not take such a right away 
from it.  It is not entirely clear whether the proponents of such a view would grant rights to every 
organism that showed signs of reacting to maltreatment. Nevertheless, they would argue that 
rights to good treatment, once granted, must be respected.
28.	Others would argue that while granting rights to animals is inappropriate because human rights 
are firmly embedded in a social context, humans have responsibilities for animals in their care and 
should ensure that their welfare is good.  Both the rights and the responsibilities arguments are 
sometimes taken as absolutes, over-riding all other moral claims.  However, this could also be the 
case for the moral argument for supporting animal experiments because of their potential medical 
benefit.
29.	The alternative to such absolutism is to respect the range of views by attempting to both minimise 
the suffering inflicted on animals used in research while maximising the scientific and medical 
gain.  This is the position enshrined in UK law governing the use of animals in research.  Balancing 
between these positions required by law is not an exact process since the assessment of scientific 
and medical benefit and that of animal suffering are both difficult to quantify and are not expressed 
in the same terms.
30.	The assessments are incommensurate and, therefore, referring to the judgement as cost-benefit 
analysis is misleading.  So the degree of suffering might be expressed as low, medium or high 
and the likely scientific and medical benefit might be similarly classified.  Research that involves 
low suffering to the animals and was likely to be highly beneficial would generally be regarded 
as acceptable.  Research that involves medium suffering but only a medium chance of generating 
a beneficial outcome would probably be deemed unacceptable–but clearly this judgement will 
depend on a consensus view derived from a judgement by those bodies responsible for granting 
approval to research projects.
31.	Criticism of the use of animals in research sometimes arises when there appears to be no immediate 
tangible health benefit of the research.  An inability to quantify the benefits of a research project 
can be seen to imply that it is frivolous or wasteful and therefore unethical.  This is an invalid 
assumption, however, as research studies that do not have direct benefit to humans or other 
animals can instead provide a vital contribution to fundamental scientific understanding that may 
provide benefit in the future.
32.	Individual experiments are similar to the individual bricks in a building, with knowledge being built 
up over a long period of time and with the benefits perhaps only being realised when the building 
or the research is completed.  On the other hand, the benefits of applied research may be easier 
to quantify.  For example, in drug development, many thousands of compounds may need to be 
tested in order to develop a new drug.  This means that in some cases the research may not be 
successful, and may seem futile, whereas in fact such work is essential in refining knowledge.
PMT


--- Page Break ---

7
P45032A
Turn over    
33.	It is therefore important when considering the ethical justification of the use of animals in research 
to realise that the development of a successful drug such as insulin or the antibiotics may result in 
saving many millions of human and animal lives.
Ethical issues surrounding the use of genetically modified animals
34.	The potential benefits of using genetically modified animals for research are great, and there is a 
strong scientific case for using such animals in order to understand human and animal disease. 
However, the use of genetically modified animals in scientific research may raise additional ethical 
issues, such as concerns about possible additional welfare costs that may arise from the use of this 
technology, and ethical questions about using animals in this way.
35.	A largely hypothetical concern with respect to genetic modification is that introducing a gene 
into an organism from a very different type of organism may lead to unforeseen interactions in 
development, leading to the emergence of animals that have serious welfare problems.  However 
the targeted genetic modification approach used to create genetically modified animals for research 
purposes is likely to be more predictable than other methods of inducing genomic changes, such 
as radiation exposure or chemical mutagens. 
36.	Intensive behavioural studies have been conducted on GM animals to monitor any adverse welfare 
implications and these have found very little difference between animals that have been genetically 
modified and those that have not.  Moreover, we should also bear in mind that animal breeders 
have been selecting for genetically determined traits for many centuries, such as the range of 
dog breeds, which are widely accepted but raise similar ethical and welfare issues to genetically 
modified animals.
Refinement, reduction and replacement in animal research
37.	The guiding principles of animal welfare are the so-called ‘three Rs’, refinement, reduction and 
replacement, first clearly defined in 1959.  This means that every effort must be made: 
	
●	
to refine the procedures so that the degree of suffering is kept to a minimum.
	
●	 to reduce the number of animals used in research to the minimum required for 
meaningful results.
	
●	
to replace the use of live animals by non-animal alternatives.
38.	Current UK legislation requires all researchers who propose to undertake laboratory or fieldwork 
involving animals to give full consideration to the three Rs and to seek independent advice and 
approval from a local ethics committee.  The approvals process for personal and project licences 
emphasises that researchers should seek, where possible, to avoid the use of animals and must 
advance sound and detailed scientific arguments for their use, explaining why no realistic alternative 
exists. Scientists must also address what is the acceptable trade off between the welfare benefits 
of the three Rs approach and the costs of not obtaining a more definite result through using intact 
animals.
39.	The principle of the three Rs is not to remove the use of animals in research, but instead to provide 
a mechanism to ensure the best possible use of animals in research.  Using animals in scientific 
research provides a bedrock for increasing understanding, and is consistent with the three Rs 
as developing our knowledge helps to enhance existing techniques using animals, as well as 
generating knowledge that underpins research studies using humans. 
PMT


--- Page Break ---

8
P45032A
Refinement
40.	Refinement is defined as ‘reducing to a minimum the incidence or severity of suffering experienced 
by those animals which have to be used’.  Refinement of experimental methods, for instance 
through adequate post-operative care, good housing, and improved anaesthesia and analgesia has 
been standard practice in biomedical research for many years.  Refinement of surgical procedures 
is frequently by technical advances but also by experimenters asking themselves some generic 
questions that can be asked prior to undertaking any invasive procedures: can I minimise the area 
of tissue at risk of damage or infection?  Can any aspect of the surgical process and subsequent 
recovery be made less troubling to the animal?
Case study on refinement
41.	A common question directed to researchers using animals is how can one be sure that the species 
being used is appropriate to the study of human health or illness. Selecting the appropriate model 
is an important step scientifically of course, but also in terms of animal welfare.  The more one can 
predict the course of the disease induced in the animal, the better one can anticipate the animal’s 
behaviours and needs such as changes in housing, diet or diurnal routine.  Use of a certain species 
for research purposes is dependent on the process or disease under study.  If one compares the 
genomes of the mouse and humans, one finds that there is a mouse homologue for 99% of human 
genes, and of the genes implicated in human disease processes, 90% are present in the mouse.  
As a consequence of this degree of similarity, major advances have been made recently by the 
development of transgenic mouse models of human neurodegenerative disease. 
42.	The identification of mutations in the SOD1 gene as the cause of Amyotrophic Lateral Sclerosis 
(ALS), a lethal neurodegenerative disease, has opened new possibilities.  Mice with mutations in 
the SOD1 gene develop severe motor neuron degeneration similar to that seen in humans and 
targeting specific mutations in SOD1 has given researchers the ability to study specific symptoms 
such as limb weakness, axonal swelling and the timing of onset of symptoms.  Genetic manipulation 
of the mouse is constantly being refined and a future possibility is to be able to switch genes on or 
off at different stages of the animal’s life – a critical step in the study of late onset neurodegenerative 
diseases.  As a result of the experimental refinements made possible by what is known as the 
‘genotype driven approach’, gene therapies for ALS and other motor neuron degeneration diseases 
(all of which are incurable) have begun to be developed.
Reduction
43.	A requirement of the Animals (Scientific Procedures) Act 1986 is that the smallest number of animals 
should be used, consistent with achieving the objectives of the experiment.  The number needed will 
depend on the variability of the animals, the minimum size of any statistically significant difference 
between treatment groups and the chances of obtaining misleadingly negative conclusions.
44.	Using animals of similar age, weight, genetic composition and so forth can reduce variability of the 
animals.  Best use of the animals can be obtained by appropriate experimental design and by correct 
statistical analysis of the data.  Failure to use good design will result in more animals being used 
than is necessary.  Poor statistical analysis will result in unnecessary waste because the conclusions 
are unreliable or the data are not used as productively as might otherwise have been the case. 
This means that researchers must be properly trained in statistics and should receive advice from a 
statistician, who is experienced in dealing with those who work with animals.
PMT


--- Page Break ---

9
P45032A
Turn over    
45.	Sound experimental design and forethought about statistical analysis are the first steps to reducing 
the number of animals used in any procedure.  Achieving a reduction in the number of animals used 
is more difficult, however, when a small number of experimental subjects would have been used 
anyway, for example in research using non-human primates.  The reduction process, like refinement, 
is led by generic questions: How can more data per animal be obtained?  Can the experiment be 
repeated with the same research subjects experiencing a variety of experimental variables?
Case study on reduction
46.	The introduction of new techniques can help reduce the numbers of animals used.  In experiments 
to investigate brain function, for example, a region of brain tissue may be permanently removed by 
surgical lesion in an attempt to understand its function.  It may be possible, however, to use reversible 
chemical lesions, or temporarily interfere with brain function through cooling by injecting chilled 
saline into the study area (Lomber 1999) to decrease the numbers of animals used.  Brain images of 
animals also provide information about the area under study, and may help to reduce the need for 
more invasive investigative methods.  It may also be possible to use advanced surgical techniques 
that obviate the need to kill the animal, as seen in the use of partial lesions to produce visual 
deficits in only one quadrant of the visual field.  Scientists were thus able to use the animals as their 
own controls by testing their perceptual functions in both the lesioned and non-lesioned part of 
the visual field representation.  These experiments were also able to maximise comparability with 
human data by training the animals in tests identical to those used with human subjects.  Thus the 
amount, quality and comparability with human data were all enhanced at the same time as the total 
number of animals used was reduced.
47.	Genetically modified animals may also offer new opportunities for refinement and reduction. 
A question often asked of animal research is how one knows whether the species being used is 
relevant. GM animals provide a means of ensuring that the characteristics of the system under 
investigation are as closely matched as possible to the human system that is the target of the 
research.  The research and potential medical benefits of GM animals are already being pursued in 
research on heart disease, cancer and muscular dystrophy.  From a refinement point of view, having 
available the most appropriate animal model increases the power of an experiment and also allows 
the most sensitive techniques and measures to be used.  These experimental refinements can 
provide answers to the three questions posed above: the best choice of animal, which may or may 
not be GM, is a first step to minimising unwanted aspects of experimental procedures. 
Replacement
48.	The use of whole animals is a key element of much scientific and medical research as it enables 
normal physiological processes to be studied within the environment of the living body, and helps 
identify interactions that influence disease processes.
49.	When a specific mechanism can be identified, the use of cell cultures may be possible.  Similarly, 
molecular sensors may be used to test the biological activity of particular substances.  When 
enough is known about a complex system found in intact animals, computer simulations could 
prove helpful in exploring the dynamics of that system; in effect, experiments can be conducted on 
the computer model.  However, such studies generally suggest and require further work on whole 
animals and do not completely replace experiments on animals.  Alternatives to whole animals are 
clearly versatile, but are as yet incapable of capturing the complexity of the living mammalian body. 
Research that would be typically carried out on animals has been conducted on humans, but when 
the outcome is unknown, as is usually the case in research, or the techniques are invasive, the ethical 
justification for such work is highly questionable – even when the human subjects are volunteers.
PMT


--- Page Break ---

10
P45032A
Case study on replacement
50.	The lesion method, studying the effects on behaviour of compromising or removing tissue, is a 
widely used experimental system in behavioural sciences.  One can, however, temporarily interfere 
with brain functions by applying brief magnetic pulses to transiently interfere with normal function. 
This method therefore replaces the need for permanent, surgical interference of brain function in 
some experiments.  In practice, this technique, called transcranial magnetic stimulation or TMS, 
has now been used to study the timing of information transfer between human cortical areas, 
changes in brain function due to learning and a wide range of perceptual, movement and language 
functions. 
51.	This ability to use human subjects in lesion experiments now obviates the need for some lesion 
experiments in non-human primates.  This is limited, however, to cases where the brain region of 
interest is accessible to surface stimulation.  Many areas of interest lie too deep to be penetrated by 
the magnetic fields, in which case surgical lesions in animals are still necessary.  A question about 
TMS is how one knows the right area has been stimulated with the same degree of certainty as total 
removal of a brain region by surgery.  However, high levels of accuracy of the TMS technique can 
be established by co-registration of the magnetic stimulation site with a human subject’s individual 
MRI scan.  TMS also has very high temporal resolution and cortical functions can be disrupted within 
time windows as small as 5 milliseconds, thus allowing a temporal dimension to lesion analysis that 
is difficult to achieve in monkeys with other methods.
52.	The principles behind these examples of the three Rs can be extended or modified to other types of 
animal research.  Reduction would seem to be the factor on which most progress can be made by 
changes in experimental design and procedures.  Refinement is an ongoing process dependent on 
new techniques and improvements in husbandry.  Researchers routinely implement refinement and 
reduction in their daily routines – it is both good science and cost effective to improve experimental 
design and increase statistical power.  The third R, replacement, is more difficult to achieve because 
of the unique insights provided by use of whole animals and because some techniques cannot of 
course be used with human subjects.  Notwithstanding the difficulties, every effort to pursue the 
three Rs should be made.
Acknowledgements
http://royalsociety.org/uploadedFiles/Royal_Society_Content/policy/publications/2004/9726.pdf
Every effort has been made to contact copyright holders to obtain their permission for the use of copyright 
material.  Edexcel, a product of Pearson Education Ltd. will, if notified, be happy to rectify any errors or omissions 
and include any such rectifications in future editions.
PMT


--- Page Break ---

11
P45032A
BLANK PAGE
PMT


--- Page Break ---

12
P45032A
BLANK PAGE
PMT
